Browsing Tag

Larimar Therapeutics

Larimar Therapeutics Announces Oral and Poster Presentations at the Upcoming…

Eli Pacheco Oct 20, 2022 0

BALA CYNWYD, Pa., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for…

Health

Larimar Therapeutics Provides Update on CTI-1601 Clinical Program

Eli Pacheco Feb 15, 2022 0

BALA CYNWYD, Pa., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for…